Drugs / DTP-IPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01926015 | Sep 2013 → Jun 2014 | Rotavirus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTP-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01926015 ↗ |
| Modality | Vaccine | “Diphtheria, tetanus, pertussis, inactivated polio vaccine used as part of the Japanese vaccination schedule” NCT01926015 ↗ |
| Route | Subcutaneous | “DTP-IPV (0.5 mL subcutaneous injection)” NCT01926015 ↗ |